Chapter 4 Biomarkers Of Liver Fibrosis-Reference-Cited by-同舟云学术

Chapter 4 Biomarkers Of Liver Fibrosis

Published:2008 Issue: Volume: Page:131-160
ISSN:0065-2423
Container-title:Advances in Clinical Chemistry
language:
Short-container-title:

Author:

Poynard Thierry,Morra Rachel,Ingiliz Patrick,Imbert‐Bismut Françoise,Thabut Dominique,Messous Djamila,Munteanu Mona,Massard Julien,Benhamou Yves,Ratziu Vlad

Publisher

Elsevier

Reference109 articles.

1. Liver biopsy;Bravo;N Engl J Med,2001

2. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection;Regev;Am J Gastroenterol,2002

3. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: The smaller the sample, the milder the disease;Colloredo;J Hepatol,2003

4. Sampling variability of liver fibrosis in chronic hepatitis C;Bedossa;Hepatology,2003

5. Sampling variability of liver biopsy in nonalcoholic fatty liver disease;Ratziu;Gastroenterology,2005

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serologic Biomarkers for Hepatic Fibrosis in Obese Children with Nonalcoholic Steatohepatitis;Pediatric Gastroenterology, Hepatology & Nutrition;2024

2. Serum infrared spectral profile is predictive of the degree of hepatic fibrosis in chronic hepatitis C patients;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2024-01

3. Chronic Liver Disease – What’s New?;Indian Journal of Pediatrics;2023-09-22

4. Serologic biomarkers and scoring systems for hepatic fibrosis in obese children with nonalcoholic steatohepatitis;2023-08-28

5. Refining imaging tools to detect advanced fibrosis: could liver surface nodularity address an unmet need in the NAFLD epidemic?;European Radiology;2022-01-27